Related Experiment Video
Updated: Feb 26, 2026

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
Published on: January 12, 2022
Evaluation of development of subclinical atherosclerosis in children with uveitis
Seçil Conkar1, Suzan Güven Yılmaz2, İlker Özgür Koska3
1Department of Pediatric Nephrology, Ege University Faculty of Medicine, İzmir, Turkey. secilcankar@yahoo.com.tr.
Insights
Children with uveitis show early signs of atherosclerosis, including increased arterial stiffness and augmentation index. Longer disease duration correlates with more advanced subclinical atherosclerosis markers.
Area of Science:
- Pediatric Rheumatology
- Cardiovascular Research
- Ophthalmology
Background:
- Uveitis is a chronic inflammatory condition linked to atherosclerosis development.
- Atherosclerosis, a major cardiovascular disease risk factor, can begin in childhood.
- Investigating subclinical atherosclerosis in children with uveitis is crucial for early detection and intervention.
Purpose of the Study:
- To assess subclinical atherosclerosis in children diagnosed with uveitis.
- To compare arterial stiffness and carotid artery intima-media thickness (cIMT) between uveitis patients and healthy controls.
- To explore the relationship between uveitis duration and atherosclerosis markers.
Main Methods:
- Seventy-five children with uveitis and 50 healthy controls were included.
- Exclusion criteria: hypertension, obesity, dyslipidemia, diabetes, and prior cardiovascular disease.
- Measurements included carotid-femoral pulse wave velocity (PWV), augmentation index (AIx), and cIMT.
Main Results:
- Patients with uveitis exhibited higher PWV and AIx compared to controls (p=0.04, p=0.03).
- No significant difference in cIMT was observed between groups initially.
- Children with uveitis duration >5 years showed elevated PWV, AIx, and cIMT (p<0.05).
Conclusions:
- Children with uveitis demonstrate early vascular dysfunction and subclinical atherosclerosis.
- Prolonged uveitis duration exacerbates atherosclerosis markers, including cIMT.
- Non-invasive atherosclerosis markers are recommended for monitoring uveitis progression and treatment efficacy.
Abstract:
Uveitis is a chronic inflammatory disease. Chronic inflammation has been shown to have a role in pathogenesis of atherosclerosis. Atherosclerosis is the most important risk factor of cardiovascular diseases and is shown to start as early as childhood. In this study, we investigated the presence of subclinical atherosclerosis in children with uveitis. Seventy five patients who were diagnosed as having uveitis in ophthalmology and pediatric rheumatology clinics were included in the study. Patients with hypertension, obesity, dyslipidemia, diabetes, and with history of early cardiovascular disease were excluded. Arterial stiffness, carotid-femoral pulse wave velocity (PWV), augmentation index (AIx), and carotid artery intima-media thickness (cIMT) were measured for each patient. These measurements were compared with 50 healthy children with similar age and sex as controls. The mean age of patients in this study was 12.24 ± 2.69 years, and the mean age of controls was 11.32 ± 4.52 years. PWV and AIx values were higher in the patient group (p = 0.04, p = 0.03). cIMT levels were not different in patient and control groups. When patients were grouped as having uveitis for more than 5 years or not, patients with longer duration of uveitis had higher PWV, AIx, and cIMT levels (p values were 0.01, 0.02, and 0.04 respectively). Vascular functions deteriorate first with endothelial damage in children with uveitis and as disease continues, increase in cIMT is added. We think that for follow-up of the disease and evaluation of the treatment, non-invasive subclinical atherosclerosis markers should be used along with activation criteria of primary diseases.
Related Concept Videos
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Atherosclerosis III: Management
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Atherosclerosis I: Introduction
Hypertension III: Clinical Manifestations and Diagnostic Studies

